#USA #New York #Inc. #Levi Korsinsky #securities action #LifeMD

Investors Alert: LifeMD, Inc. in Legal Trouble

LifeMD, Inc. (NASDAQ: LFMD), a company on the move in the health sector, is now at the center of a class action lawsuit initiated by Levi & Korsinsky, LLP. This legal challenge raises serious questions about the company's financial disclosures and operational statements made between May 7, 2025, and August 5, 2025.

Background of the Case

The lawsuit aims to recover losses for investors who believe they were misled by LifeMD concerning its competitive standing and future prospects. The allegations suggest that the company, underreported the challenges it faced, particularly regarding customer acquisition costs that are essential to its revenue model. It specifically claims that LifeMD exaggerated its position in the market, which may have clouded investor judgment.

During the relevant timeframe, stakeholders are alleging that the company made various false statements that did not just undermine trust but also led to significant financial losses for investors. Key issues in the complaint include:

• - LifeMD’s failure to accurately disclose rising customer acquisition costs, specifically relating to its RexMD segment.
• - Misleading forecasts about 2025 revenue, raising expectations with no substantial backing.
• - Statements about their pipeline of weight-loss medications such as Wegovy and Zepbound were allegedly overstated, contributing to unrealistic market hopes.

What Investors Need to Know

If you are among those who invested in LifeMD and experienced a financial setback during the specified period, it’s crucial to act promptly. Interested parties have until October 25, 2025, to apply for the position of lead plaintiff in this class-action suit. Taking on this role grants a participant a more significant say in how the case unfolds, although it is not a prerequisite for receiving compensation.

Participation in this lawsuit carries no financial burden to the plaintiff—those who join as class members may do so without any up-front costs. Levi & Korsinsky assures that there won’t be any out-of-pocket costs incurred by investors who choose to join the action.

Why Choose Levi & Korsinsky?

For over two decades, Levi & Korsinsky has advocated for aggrieved shareholders, managing to secure settlements worth hundreds of millions of dollars in various high-stakes lawsuits. Their impressive track record is supported by a robust team and extensive experience in dealing with complex securities litigation. Over 70 knowledgeable professionals are committed to assisting clients through thick and thin.

The firm ranks consistently in the top tiers of securities litigation firms in the United States, according to ISS Securities Class Action Services, which speaks volumes about their capabilities.

Next Steps: How to Get Involved

If you have been impacted by the alleged misrepresentations of LifeMD, the first step is to fill out the class action submission form available here. You can also contact attorney Joseph E. Levi directly at (212) 363-7500 or through email for any inquiries. The firm will navigate through the legal complexities to ensure investors' rights are upheld.

Conclusion

The landscape of corporate operations can be riddled with signals that may appear as promising, yet not all are as genuine as presented. As this lawsuit unfolds, its implications for LifeMD, its investors, and the industry landscape as a whole remain to be seen. Nonetheless, affected shareholders are granted a crucial opportunity to secure their rights through this class action suit.